Shop Amazon Smile This Holiday Season We continually try to answer the question that so many of you ask us: How can I help? Here…
FDA Approves KEYTRUDA for Stage IIB and IIC Melanoma Patients December 4, 2021 (Richmond, California) Yesterday, Merck announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda…
THE GRATITUDE GALA: AIM’s 3rd Annual No Show Gala & Online Auction What is a “no-show” gala? AIM at Melanoma’s Third Annual No Show Gala & Auction is a unique fundraiser that…
Relatlimab/Nivolumab Application for Frontline Advanced Melanoma Validated by EMA October 1, 2021 Kristi Rosa REPOST from OncLive The European Medicines Agency has validated its marketing authorization application for the…
Vaccines 2021—Major Advances in Preventing Death from Infection and Malignancy By Kim Margolin, M.D., FACP, FASCO Vaccine background and brief history The word “vaccine” comes from the Latin word vacca…
Using Facebook For Good One of the most common questions we are asked here at AIM by patients, families, and friends is How can…
FDA Takes Steps Aimed at Improving Quality, Safety and Efficacy of Sunscreens For Immediate Release: September 24, 2021 (repost from FDA) The U.S. Food and Drug Administration today took steps aimed at…
International Survivor Spotlight: José Correia, Portugal By Mara Klecker José Correia’s melanoma diagnosis was nearly a quarter-century ago, but he is committed to spreading awareness about…
Making the Cut For Melanoma: A Mom’s Motivation By Mara Klecker As a social service director working in long-term care, Traci Cunningham made a promise to her…
President’s Letter | September 2021 From the Desk of Samantha Guild As I reviewed the articles for this month’s newsletter, I thought about the fact…